138 related articles for article (PubMed ID: 34118472)
1. A homozygous nonsense mutation early in exon 5 of BRCA2 is associated with very severe Fanconi anemia.
Radulovic I; Kuechler A; Schündeln MM; Paulussen M; von Neuhoff N; Reinhardt D; Hanenberg H
Eur J Med Genet; 2021 Aug; 64(8):104260. PubMed ID: 34118472
[TBL] [Abstract][Full Text] [Related]
2. Fanconi anemia with biallelic FANCD1/BRCA2 mutations - Case report of a family with three affected children.
Svojgr K; Sumerauer D; Puchmajerova A; Vicha A; Hrusak O; Michalova K; Malis J; Smisek P; Kyncl M; Novotna D; Machackova E; Jencik J; Pycha K; Vaculik M; Kodet R; Stary J
Eur J Med Genet; 2016 Mar; 59(3):152-7. PubMed ID: 26657402
[TBL] [Abstract][Full Text] [Related]
3. A novel cancer risk prediction score for the natural course of FA patients with biallelic BRCA2/FANCD1 mutations.
Radulovic I; Schündeln MM; Müller L; Ptok J; Honisch E; Niederacher D; Wiek C; Scheckenbach K; Leblanc T; Larcher L; Soulier J; Reinhardt D; Schaal H; Andreassen PR; Hanenberg H
Hum Mol Genet; 2023 May; 32(11):1836-1849. PubMed ID: 36721989
[TBL] [Abstract][Full Text] [Related]
4. The clinical phenotype of children with Fanconi anemia caused by biallelic FANCD1/BRCA2 mutations.
Myers K; Davies SM; Harris RE; Spunt SL; Smolarek T; Zimmerman S; McMasters R; Wagner L; Mueller R; Auerbach AD; Mehta PA
Pediatr Blood Cancer; 2012 Mar; 58(3):462-5. PubMed ID: 21548014
[TBL] [Abstract][Full Text] [Related]
5. Biallelic BRCA2 mutations in two black South African children with Fanconi anaemia.
Feben C; Spencer C; Lochan A; Laing N; Fieggen K; Honey E; Wainstein T; Krause A
Fam Cancer; 2017 Jul; 16(3):441-446. PubMed ID: 28185119
[TBL] [Abstract][Full Text] [Related]
6. Genotype-cancer association in patients with Fanconi anemia due to pathogenic variants in FANCD1 (BRCA2) or FANCN (PALB2).
McReynolds LJ; Biswas K; Giri N; Sharan SK; Alter BP
Cancer Genet; 2021 Nov; 258-259():101-109. PubMed ID: 34687993
[TBL] [Abstract][Full Text] [Related]
7. BRCA2 minor transcript lacking exons 4-7 supports viability in mice and may account for survival of humans with a pathogenic biallelic mutation.
Thirthagiri E; Klarmann KD; Shukla AK; Southon E; Biswas K; Martin BK; North SL; Magidson V; Burkett S; Haines DC; Noer K; Matthai R; Tessarollo L; Loncarek J; Keller JR; Sharan SK
Hum Mol Genet; 2016 May; 25(10):1934-1945. PubMed ID: 26920070
[TBL] [Abstract][Full Text] [Related]
8. Biallelic inactivation of BRCA2 in Fanconi anemia.
Howlett NG; Taniguchi T; Olson S; Cox B; Waisfisz Q; De Die-Smulders C; Persky N; Grompe M; Joenje H; Pals G; Ikeda H; Fox EA; D'Andrea AD
Science; 2002 Jul; 297(5581):606-9. PubMed ID: 12065746
[TBL] [Abstract][Full Text] [Related]
9. Genetic reversion in an acute myelogenous leukemia cell line from a Fanconi anemia patient with biallelic mutations in BRCA2.
Ikeda H; Matsushita M; Waisfisz Q; Kinoshita A; Oostra AB; Nieuwint AW; De Winter JP; Hoatlin ME; Kawai Y; Sasaki MS; D'Andrea AD; Kawakami Y; Joenje H
Cancer Res; 2003 May; 63(10):2688-94. PubMed ID: 12750298
[TBL] [Abstract][Full Text] [Related]
10. Inducibility of nuclear Rad51 foci after DNA damage distinguishes all Fanconi anemia complementation groups from D1/BRCA2.
Godthelp BC; Wiegant WW; Waisfisz Q; Medhurst AL; Arwert F; Joenje H; Zdzienicka MZ
Mutat Res; 2006 Feb; 594(1-2):39-48. PubMed ID: 16154163
[TBL] [Abstract][Full Text] [Related]
11. A cross-linker-sensitive myeloid leukemia cell line from a 2-year-old boy with severe Fanconi anemia and biallelic FANCD1/BRCA2 mutations.
Meyer S; Fergusson WD; Oostra AB; Medhurst AL; Waisfisz Q; de Winter JP; Chen F; Carr TF; Clayton-Smith J; Clancy T; Green M; Barber L; Eden OB; Will AM; Joenje H; Taylor GM
Genes Chromosomes Cancer; 2005 Apr; 42(4):404-15. PubMed ID: 15645491
[TBL] [Abstract][Full Text] [Related]
12. Fanconi anemia and solid malignancies in childhood: a national retrospective study.
Malric A; Defachelles AS; Leblanc T; Lescoeur B; Lacour B; Peuchmaur M; Maurage CA; Pierron G; Guillemot D; d'Enghien CD; Soulier J; Stoppa-Lyonnet D; Bourdeaut F
Pediatr Blood Cancer; 2015 Mar; 62(3):463-70. PubMed ID: 25381700
[TBL] [Abstract][Full Text] [Related]
13. Clinical and molecular features associated with biallelic mutations in FANCD1/BRCA2.
Alter BP; Rosenberg PS; Brody LC
J Med Genet; 2007 Jan; 44(1):1-9. PubMed ID: 16825431
[TBL] [Abstract][Full Text] [Related]
14. Hepatoblastoma in a 4-year-old girl with Fanconi anaemia.
Kopic S; Eirich K; Schuster B; Hanenberg H; Varon-Mateeva R; Rittinger O; Schimpl G; Schindler D; Jones N
Acta Paediatr; 2011 May; 100(5):780-3. PubMed ID: 21138478
[TBL] [Abstract][Full Text] [Related]
15. Fanconi anemia caused by biallelic inactivation of BRCA2 can present with an atypical cancer phenotype in adulthood.
Maxwell KN; Patel V; Nead KT; Merrill S; Clark D; Jiang Q; Wubbenhorst B; D'Andrea K; Cohen RB; Domchek SM; Morrissette JJD; Greenberg RA; Babushok DV; Nathanson KL
Clin Genet; 2023 Jan; 103(1):119-124. PubMed ID: 36089892
[TBL] [Abstract][Full Text] [Related]
16. Distinct roles of BRCA2 in replication fork protection in response to hydroxyurea and DNA interstrand cross-links.
Rickman KA; Noonan RJ; Lach FP; Sridhar S; Wang AT; Abhyankar A; Huang A; Kelly M; Auerbach AD; Smogorzewska A
Genes Dev; 2020 Jun; 34(11-12):832-846. PubMed ID: 32354836
[TBL] [Abstract][Full Text] [Related]
17. Fanconi anemia and biallelic BRCA2 mutation diagnosed in a young child with an embryonal CNS tumor.
Dewire MD; Ellison DW; Patay Z; McKinnon PJ; Sanders RP; Gajjar A
Pediatr Blood Cancer; 2009 Dec; 53(6):1140-2. PubMed ID: 19530235
[TBL] [Abstract][Full Text] [Related]
18. Amplification and translocation of 3q26 with overexpression of EVI1 in Fanconi anemia-derived childhood acute myeloid leukemia with biallelic FANCD1/BRCA2 disruption.
Meyer S; Fergusson WD; Whetton AD; Moreira-Leite F; Pepper SD; Miller C; Saunders EK; White DJ; Will AM; Eden T; Ikeda H; Ullmann R; Tuerkmen S; Gerlach A; Klopocki E; Tönnies H
Genes Chromosomes Cancer; 2007 Apr; 46(4):359-72. PubMed ID: 17243162
[TBL] [Abstract][Full Text] [Related]
19. Shared genetic susceptibility to breast cancer, brain tumors, and Fanconi anemia.
Offit K; Levran O; Mullaney B; Mah K; Nafa K; Batish SD; Diotti R; Schneider H; Deffenbaugh A; Scholl T; Proud VK; Robson M; Norton L; Ellis N; Hanenberg H; Auerbach AD
J Natl Cancer Inst; 2003 Oct; 95(20):1548-51. PubMed ID: 14559878
[TBL] [Abstract][Full Text] [Related]
20. Fanconi anemia in Tunisia: high prevalence of group A and identification of new FANCA mutations.
Bouchlaka C; Abdelhak S; Amouri A; Ben Abid H; Hadiji S; Frikha M; Ben Othman T; Amri F; Ayadi H; Hachicha M; Rebaï A; Saad A; Dellagi K;
J Hum Genet; 2003; 48(7):352-61. PubMed ID: 12827451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
